Direct preconditioning of cultured chick ventricular myocytes: Novel functions of cardiac adenosine A(2a) and A3 receptors

Journal of Clinical Investigation

Volumn 98, Issue 8, 1996, Pages 1773-1779

  Strickler, Jennifer ^a   Jacobson, Kenneth A ^b   Liang, Bruce T ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

adenosine; ischemia; myocardium; purinergic; receptor

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; FORSKOLIN; ISOPRENALINE; NIFEDIPINE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029998603     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118976     Document Type: Article

References (38)

1. Murry, C.E., R.B. Jennings, and K.A. Reimer. 1986. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 74: 1124-1136.
2. Downey, J.M. 1992. Ischemic preconditioning. Nature's own cardio protective intervention. Trends Cardiovasc. Med. 2:170-176.
3. Ely, S.W., and R.M. Berne. 1992. Protective effects of adenosine in myocardial ischemia. Circulation. 85:893-904.
4. Li, G.C., J.A. Vasquez, K.P. Gallagher, and B.R. Lucchesi. 1990. Myocardial protection with preconditioning. Circulation. 82:609-619.
5. Deutsch, E., M. Berger, W.G. Kussmaul, J.W. Hirshfield, H.C. Hermann, and W.K. Laskey. 1990. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic-features. Circulation. 82:2044-2051.
6. Cribier, A.L., R. Korsatz, R. Koning, P. Rath, H. Gamra, G. Stix, S. Merchant, C. Chan, and B. Letac. 1992. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study. J. Am. Coll. Cardiol. 20:578-586.
7. Olafsson, B., M.B. Forman, D.W. Puett. A. Pou, and C.U. Cates. 1987. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation. 75:1135-1145.
8. Babbitt, D.G., R. Virmani, and M.B. Forman. 1989. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation. 80:1388-1399.
9. Wyatt, D.A., S.W. Ely, R.D. Lasley, R. Walsh, R. Mainwaring, R.M. Berne, and R.M. Mentzer. 1989. Purine-enriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves post ischemic ventricular function. J. Thorac. Cardiovasc. Surg. 97:771-778.
10. Miura, T., T. Ogawa, T. Iwamoto, K. Shimamoto, and O. Iimura. 1992. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation. 86:979-985.
11. Auchampach, J.A., G.J. Grover, and G.J. Gross. 1992. Blockade of ischemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovas. Res. 26:1054-1062.
12. ATP channels. Circulation. 89:1229-1236.
13. Schulz, R., J. Rose, and G. Heusch. 1994. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am. J. Physiol. 267:H1341-H1352.
14. Tomai, F., F. Crea, A. Caspardone, F. Versaci, R. DePaulis, A. Penta de Peppo, L. Chiariello, and P.A. Gioffré. 1994. Ischemic preconditioning during coronary angioplasty is prevented by glibencladmide, a selective ATP-sensitive K+ channel blocker. Circulation. 90:700-705.
15. Armstrong, S., and C.E. Ganote. 1994. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc. Res. 28:1049-1056.
16. Ikonomidis, J.S., L.C. Tumiati, R.D. Weisel, D.A.G. Mickle, and R.-K. Li. 1994. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc. Res. 28:1285-1291.
17. Webster, K.A., D.J. Discher, and N.H. Bishopric. 1995. Cardioprotection in an in vitro model of hypoxic preconditioning. J. Mol. Cell. Cardiol. 27:453-458.
18. DeHaan, R.L. 1967. Developmental changes in the calcium currents in embryonic chick ventricular myocytes. Dev. Biol. 16:216-249.
19. Galper, J.B., and T.W. Smith. 1978. Properties of muscarinic acetylcholine receptors in heart cell cultures. Proc. Natl. Acad. Sci. USA. 75:5831-5835.
20. Barry, W.H., and T.W. Smith. 1982. Mechanisms of transmembrane calcium movement in cultured chick embryo ventricular cells. J. Physiol. 325:243-260.
21. Marsh, J.D., D. Lachance, and D. Kim. 1985. Mechanism of β-adrenergic receptor regulation in cultured chick heart cells. Circ. Res. 57:171-181.
22. Liang, B.T., M.R. Hellmich, E.J. Neer, and J.B. Galper. 1986. Development of muscarinic cholinergic inhibition of adenylate cyclase in embryonic chick hearts: its relationship to changes in the inhibitory guanine nucleotide regulatory protein. J. Biol. Chem. 261:9011-9021.
23. Stimers, J.R., S. Liu, and M.J. Lieberman. 1991. Apparent affinity of the Na/K pump for ouabain in cultured chick cardiac myocytes. J. Gen. Physiol. 98:815-833.
24. Xu, H., J. Miller, and B.T. Liang. 1992. High-efficiency gene transfer into cardiac myocytes. Nucleic Acids Res. 20:6425-6426.
25. Liang, B.T. 1992. Adenosine Receptors and Cardiovascular Function. Trends Cardiovasc. 2:100-108.
26. Liang, B.T. 1989. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: Coupling to modulation of contractility and adenylyl cyclase activity and identification by direct radioligand binding. J. Pharmacol. Exp. Ther. 249:775-784.
27. 2b receptors in cultured fetal chick ventricular cells. High- and low-affinity coupling to stimulation of myocyte contractility and cyclic AMP accumulation. Circ. Res. 76: 242-251.
28. 2a receptor in the intact cardiac cell. J. Biol. Chem. 271:18678-18685.
29. Mestril, R., S.-H. Chi, M.R. Sayen, K. O'Reilly, and W.H. Dillmann. 1994. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J. Clin. Invest. 93: 759-767.
30. Hori, M., M. Inoue, M. Kitakaz, Y. Koretsune, K. Iwai, J. Tamai, H. Ito, A. Kitabatake, T. Sato, and T. Kamada. 1986. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am. J. Physiol. 250:H509-H518.
31. Yamane, R., T. Nakamura, E. Matuura, H. Ishige, and M. Fujimoto. 1991. A simple and sensitive radioimmunoassay for adenosine. J. Immunoassay. 12:501-509.
32. Tietz, N.W. 1983. Fundamentals of Clinical Chemistry. W.B. Saunders Co., Philadelphia, PA.
33. 2-adenosine antagonist in vitro and in vivo. FEBS Lett 323:141-144.
34. 3-selective adenosine agonists. J. Med. Chem. 37:636-646.
35. 3 adenosine receptors. J. Med. Chem. 37:3614-3621.
36. Van Wylen, D.G.L. 1994. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation. 89:2283-2289.
37. Dobson, J.G., Jr. 1983. Mechanism of adenosine inhibition of catecholamine-induced responses in the heart. Circ. Res. 52:151-160.
38. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res. 28:1057-1061.